Tools & Calculators
Stocks
F&O
Mutual Funds
SBI Healthcare Opportunities Reg IDCW-R
as of 23 Apr 2026, 09:08 AM
Invested Amount
Est. Return
Total Value
rated by Value Research
Your principal will be at Very High Risk
Absolute Returns
CAGR
Company Name | Sector | Instrument | Assets |
|---|---|---|---|
| Sun Pharmaceuticals Industries Ltd | Healthcare | E | 12.11% |
| Divi's Laboratories Ltd | Healthcare | E | 6.59% |
| Acutaas Chemicals Ltd | Basic Materials | E | 5.67% |
| Apollo Hospitals Enterprise Ltd | Healthcare | E | 5.48% |
| Max Healthcare Institute Ltd Ordinary Shares | Healthcare | E | 4.97% |
| Lupin Ltd | Healthcare | E | 4.10% |
| Aster DM Healthcare Ltd Ordinary Shares | Healthcare | E | 3.96% |
| Torrent Pharmaceuticals Ltd | Healthcare | E | 3.74% |
| Aether Industries Ltd | Basic Materials | E | 3.56% |
| Biocon Ltd | Healthcare | E | 3.33% |
| Anthem Biosciences Ltd | Healthcare | E | 3.17% |
| Mankind Pharma Ltd | Healthcare | E | 3.16% |
| Lonza Group Ltd ADR | Healthcare | E | 2.97% |
| Fortis Healthcare Ltd | Healthcare | E | 2.93% |
| Laurus Labs Ltd | Healthcare | E | 2.93% |
| Jupiter Life Line Hospitals Ltd | Healthcare | E | 2.84% |
| Alkem Laboratories Ltd | Healthcare | E | 2.61% |
| Aurobindo Pharma Ltd | Healthcare | E | 2.57% |
| Gland Pharma Ltd | Healthcare | E | 2.50% |
| Krishna Institute of Medical Sciences Ltd | Healthcare | E | 2.45% |
| Sai Life Sciences Ltd | Healthcare | E | 2.24% |
| Ajanta Pharma Ltd | Healthcare | E | 2.07% |
| Sudeep Pharma Ltd | Healthcare | E | 1.98% |
| Abbott India Ltd | Healthcare | E | 1.91% |
| Poly Medicure Ltd | Healthcare | E | 1.88% |
| Concord Biotech Ltd | Healthcare | E | 1.80% |
| Nephrocare Health Services Ltd | Healthcare | E | 1.00% |
| Cohance Lifesciences Ltd | Healthcare | E | 0.89% |
| Sanofi Consumer Healthcare India Ltd | Healthcare | E | 0.63% |
| Gufic Biosciences Ltd | Healthcare | E | 0.54% |
| Vijaya Diagnostic Centre Ltd | Healthcare | E | 0.53% |
| Medplus Health Services Ltd | Healthcare | E | 0.41% |
| Rainbow Childrens Medicare Ltd | Healthcare | E | 0.35% |
| Corona Remedies Ltd | Healthcare | E | 0.29% |
| 19/11/2026 Maturing 364 DTB | - | BT | 0.07% |
| Treps | - | CR | 3.36% |
| Net Receivable / Payable | - | CA | 1.59% |
| Pfizer Ltd | - | E | - |
Equity / Debt / Cash Split
Equity
98.15%
Debt
0.07%
Cash
1.78%
Equity sector allocation
Basic Materials
9.22%
Healthcare
88.93%
Others
1.85%
Asset Management Company

Nippon India Taiwan Equity Reg Gr
Equity
Min. Investment
₹500
Category Returns
32.37%
61.10%
3Y Returns
+61.10%

Mirae Asset NYSE FANG+ ETF FoF Reg Gr
Equity
Min. Investment
₹5000
Category Returns
32.37%
61.10%
3Y Returns
+48.34%

DSP Wld Gld Mng Ovrs Eq Omni FoF Gr
Equity
Min. Investment
₹100
Category Returns
32.37%
61.10%
3Y Returns
+45.98%
Investment Objective of the Scheme
Key Features of The Fund
5-year return
+15.36%
Fund Manager
Tanmaya Desai
Risk Profile
Very High Risk
Expense Ratio
1.93%
Fund Size
₹4063.64 Cr
The SBI Healthcare Opportunities Reg IDCW-R has invested the majority of its money in the stocks of the following companies:
| Company | Percentage of Portfolio |
|---|---|
| Sun Pharmaceuticals Industries Ltd | 12.11% |
| Divi's Laboratories Ltd | 6.59% |
| Acutaas Chemicals Ltd | 5.67% |
| Apollo Hospitals Enterprise Ltd | 5.48% |
| Max Healthcare Institute Ltd Ordinary Shares | 4.97% |
| Lupin Ltd | 4.10% |
| Aster DM Healthcare Ltd Ordinary Shares | 3.96% |
| Torrent Pharmaceuticals Ltd | 3.74% |
| Aether Industries Ltd | 3.56% |
| Biocon Ltd | 3.33% |
| Anthem Biosciences Ltd | 3.17% |
| Mankind Pharma Ltd | 3.16% |
| Lonza Group Ltd ADR | 2.97% |
| Fortis Healthcare Ltd | 2.93% |
| Laurus Labs Ltd | 2.93% |
| Jupiter Life Line Hospitals Ltd | 2.84% |
| Alkem Laboratories Ltd | 2.61% |
| Aurobindo Pharma Ltd | 2.57% |
| Gland Pharma Ltd | 2.50% |
| Krishna Institute of Medical Sciences Ltd | 2.45% |
| Sai Life Sciences Ltd | 2.24% |
| Ajanta Pharma Ltd | 2.07% |
| Sudeep Pharma Ltd | 1.98% |
| Abbott India Ltd | 1.91% |
| Poly Medicure Ltd | 1.88% |
| Concord Biotech Ltd | 1.80% |
| Nephrocare Health Services Ltd | 1.00% |
| Cohance Lifesciences Ltd | 0.89% |
| Sanofi Consumer Healthcare India Ltd | 0.63% |
| Gufic Biosciences Ltd | 0.54% |
| Vijaya Diagnostic Centre Ltd | 0.53% |
| Medplus Health Services Ltd | 0.41% |
| Rainbow Childrens Medicare Ltd | 0.35% |
| Corona Remedies Ltd | 0.29% |
| 19/11/2026 Maturing 364 DTB | 0.07% |
| Treps | 3.36% |
| Net Receivable / Payable | 1.59% |
| Pfizer Ltd | - |
The SBI Healthcare Opportunities Reg IDCW-R has invested the majority of its money in the stocks of the following sectors -
| Company | Percentage of Portfolio |
|---|---|
| Basic Materials | 9.22% |
| Communication Services | - |
| Consumer Cyclical | - |
| Consumer Defensive | - |
| Energy | - |
| Financial Services | - |
| Healthcare | 88.93% |
| Industrials | - |
| Real Estate | - |
| Technology | - |
| Utilities | - |
Investing in mutual funds is easy on HDFC SKY.
Follow these simple steps to invest in SBI Healthcare Opportunities Reg IDCW-R:
The exit load of SBI Healthcare Opportunities Reg IDCW-R is as follows:
Exit load of 0.5%, if redeemed within 1 year
.The following are the Steps to Redeem mutual funds on HDFC SKY:
1. Go to Mutual Funds > My Investments/Portfolio.
2. Select the fund and tap Redeem/Sell.
3. Choose Full, Units, or Amount.
4. Review NAV, units, and exit load.
5. Confirm. Amount (Units × NAV) is credited to the registered bank in T+1–T+3 days. ELSS has a 3-year lock-in.
By signing up I certify terms, conditions & privacy policy